The STING agonist 5,6‐dimethylxanthone‐4‐acetic acid (DMXAA) is known to aggravate psoriasis symptoms and skin inflammation, while the STING antagonist H‐151 exhibits anti‐inflammatory activity in imiquimod (IMQ)‐induced psoriasis mice,308, 309 it can be concluded from these results that STING activation promotes the occurrence of psoriasis inflammation. The gene discussed is STING1; the disease is psoriasis.